DashboardPortfoliosWatchlistCommunityDiscoverScreener
NOT FOR DISTRIBUTION
Loading...
  • Stocks
  • /
  • Household
Updated 3h ago
COS logo

Cosma S.A.WSE:COS Stock Report

Market Cap zł62.1m
Updated 3h ago
Share Price
n/a
1Y18.6%
7D-1.0%
1D-1.0%
Portfolio Value
​
View

Cosma S.A.

WSE:COS Stock Report

Market Cap: zł62.1m

  • Company Overview
    • Valuation
    • Future Growth
    • Past Performance
    • Financial Health
    • Dividend
  • Management
  • Ownership
  • Other Information
  • Stock Community

Cosma (COS) Stock Overview

Engages in the manufacture and selling dietary supplements, cosmetics, and pharmaceutical raw materials based on natural ingredients, including hemp in Poland. More details

COS fundamental analysis
Snowflake Score
Valuation1/6
Future Growth0/6
Past Performance0/6
Financial Health2/6
Dividends0/6

Risk Analysis

Has less than 1 year of cash runway

Highly volatile share price over the past 3 months compared to the Polish market

Earnings have declined by 33.7% per year over past 5 years

Does not have a meaningful market cap (PLN62M)


COS Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

NEW443,000 members

Join community and earn perks

Gain real feedbackFrom our editorial team, personally. Not silence.
Grow your followingReal investors. The kind who actually invest, not scroll past.
Unlock free accessFree premium subscription for consistent and quality authors.
Learn moreCreate Narrative
B
BlackGoat
R
RockeTeller
I
Investingwilly
D
davidlsander
443,000 investors already sharing narratives
zł
Current Price
zł0.4079.0% undervalued intrinsic discount
%/yr
Decrease
Increase
PastFuture-47m330m2016201920222025202620282031Revenue zł330.0mEarnings zł33.3m
Advanced
View all narratives

Cosma S.A. Competitors

Pharmena

Symbol: WSE:PHR
Market cap: zł34.3m

4MASS Spólka Akcyjna

Symbol: WSE:4MS
Market cap: zł126.8m

Harper Hygienics

Symbol: WSE:HRP
Market cap: zł31.7m

Miraculum

Symbol: WSE:MIR
Market cap: zł26.5m

Price History & Performance

Summary of share price highs, lows and changes for Cosma
Historical stock prices
Current Share Pricezł0.40
52 Week Highzł0.50
52 Week Lowzł0.31
Beta-0.48
1 Month Change7.61%
3 Month Change10.00%
1 Year Change18.56%
3 Year Change-18.85%
5 Year Change-78.24%
Change since IPO-90.73%

Recent News & Updates

Analysis Article • Jan 12

Would Cosma (WSE:COS) Be Better Off With Less Debt?

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...

Recent updates

Analysis Article • Jan 12

Would Cosma (WSE:COS) Be Better Off With Less Debt?

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...
Analysis Article • Jun 11

Does Cosma (WSE:COS) Have A Healthy Balance Sheet?

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Analysis Article • Jan 29

With EPS Growth And More, Vabun (WSE:VAB) Is Interesting

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...

Shareholder Returns

COSPL Personal ProductsPL Market
7D-1.0%-0.3%0.7%
1Y18.6%-19.6%37.5%

Return vs Industry: COS exceeded the Polish Personal Products industry which returned -19.6% over the past year.

Return vs Market: COS underperformed the Polish Market which returned 37.5% over the past year.

Price Volatility

Is COS's price volatile compared to industry and market?
COS volatility
COS Average Weekly Movement11.0%
Personal Products Industry Average Movement4.2%
Market Average Movement4.5%
10% most volatile stocks in PL Market9.3%
10% least volatile stocks in PL Market2.8%

Stable Share Price: COS's share price has been volatile over the past 3 months compared to the Polish market.

Volatility Over Time: COS's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of Polish stocks.

About the Company

FoundedEmployeesCEOWebsite
201531Przemyslaw Lahutawww.cosma.pl

Cosma S.A. engages in the manufacture and selling dietary supplements, cosmetics, and pharmaceutical raw materials based on natural ingredients, including hemp in Poland. The company’s portfolio includes proprietary brands such as Cosma, Full Spectrum, and Green Paw, offering cannabinoid dietary supplements, cannabinoid cosmetics, hemp food products, feed additives, and plant extracts for both human and pet markets. It also engages in the import and distribution of pharmaceutical raw materials for the preparation of prescription drugs.

Cosma S.A. Fundamentals Summary

How do Cosma's earnings and revenue compare to its market cap?
COS fundamental statistics
Market capzł62.11m
Earnings (TTM)-zł472.64k
Revenue (TTM)zł21.46m
2.9x
P/S Ratio
-130.1x
P/E Ratio

Is COS overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
COS income statement (TTM)
Revenuezł21.46m
Cost of Revenuezł7.98m
Gross Profitzł13.48m
Other Expenseszł13.95m
Earnings-zł472.64k

Last Reported Earnings

Jun 30, 2026

Next Earnings Date

Nov 16, 2026

Earnings per share (EPS)-0.003
Gross Margin62.82%
Net Profit Margin-2.20%
Debt/Equity Ratio169.8%

How did COS perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/09/14 20:05
End of Day Share Price 2026/09/14 00:00
Earnings2026/06/30
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
  • SEC Form 10-K
  • SEC Form 10-Q
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
  • Analyst Research Reports
  • Blue Matrix
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
  • ICE Market Data
  • SEC Form S-1
Ownership10 years
  • Top shareholders
  • Insider trading
  • SEC Form 4
  • SEC Form 13D
Management10 years
  • Leadership team
  • Board of directors
  • SEC Form 10-K
  • SEC Form DEF 14A
Key Developments10 years
  • Company announcements
  • SEC Form 8-K

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Cosma S.A. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide